Infectious diseases and therapy, 2193-6382

Journal

View graph of relations

Related Publications
  1. Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium

    Wasserman, M. D., Sings, H. L., Wilson, M. R., Postma, M. J., Breton, M-C., McDade, C. & Farkouh, R. A., Mar-2019, In : Infectious diseases and therapy. 8, 1, p. 1-3

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada"

    Wilson, M. R., Wasserman, M., Jadavji, T., Postma, M., Breton, M-C., Peloquin, F., Earnshaw, S. R., McDade, C., Sings, H. L. & Farkouh, R., Dec-2018, In : Infectious diseases and therapy. 7, 4, p. 539-543 5 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  3. Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada

    Wilson, M., Wasserman, M., Jadavi, T., Postma, M., Breton, M-C., Peloquin, F., Earnshaw, S., McDade, C., Sings, H. & Farkouh, R., Sep-2018, In : Infectious diseases and therapy. 7, 3, p. 353-371 19 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (3) »

ID: 63050781